Skip to main content
OpenTrials
Completed

NCT Number: NCT04789512

Respiratory Muscle Strength in Volleyball Players Suffered From COVID-19

In literature, there is no data evaluating respiratory functions in volleyball players during Covid-19 pandemic. The aim of this study is to evaluate and compared pulmonary functions, respiratory muscle strength, body compositions and performance situations perceptions in female volleyball players with Covid-19 and non-Covid-19.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Covid19 COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

15 year–35 year

Sex eligibility

Female

Study type

Observational

Primary location

Gazi University

Ankara, Çankaya, 06490, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • having passed at least 30 days after the Polymerase Chain Reaction (PCR) test turned negative
  • willing to participate in the study

Exclusion criteria

  • having a history of chronic lung disease
  • unwilling to participate in the study

Treatment and study plan

Respiratory functions

Other

Respiratory muscle strength, pulmonary functions and body composition were evaluated in volleyball players

Primary outcomes

  1. Respiratory muscle strength

    Time frame: 10 minute

    Maximal inspiratory and expiratory muscle strength will be evaluated using mouth pressure device.

Secondary outcomes

  1. FEV1

    Time frame: 5 minute

    Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FEV1 will be evaluated. The percentage of predicted value <70% will be expressed as abnormal.

  2. FVC

    Time frame: 5 minute

    Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FVC will be evaluated. The percentage of predicted value <70% will be expressed as abnormal

  3. FEV1/FVC

    Time frame: 5 minute

    Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FEV1/FVC will be evaluated.

  4. PEF

    Time frame: 5 minute

    Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. PEF will be evaluated. The percentage of predicted value <70% will be expressed as abnormal.

  5. FEF2575

    Time frame: 5 minute

    Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FEF2575 will be evaluated. The percentage of predicted value <50% will be expressed as abnormal.

  6. Fat mass

    Time frame: 2 minute

    Fat mass will be evaluated using TANITA bioelectrical impedance analysis.

  7. Fat mass percent

    Time frame: 2 minute

    Fat mass percent will be evaluated using TANITA bioelectrical impedance analysis.

  8. Fat-free mass

    Time frame: 2 minute

    Fat-free mass will be evaluated using TANITA bioelectrical impedance analysis.

  9. Body mass index

    Time frame: 2 minute

    Body mass index will be evaluated using TANITA bioelectrical impedance analysis.

  10. Predicted muscle mass

    Time frame: 2 minute

    Predicted muscle mass will be evaluated using TANITA bioelectrical impedance analysis.

  11. Symptom severity perceptions

    Time frame: 1 minute

    Symptom severity perceptions will be evaluated Numeric Rating Scale.The severity of symptoms perceptions related to Covid are scored 0-10 point. Higher scores indicate higher severity of symptoms.

  12. Performance situations perceptions

    Time frame: 1 minute

    Performance situations perceptions will be evaluated Numeric Rating Scale. Performance situations perceptions of all players are also scored 0-10 point. Higher scores indicate greater performance.

Sponsors and collaborators

Lead sponsor

Gazi University

Other

Registry information

Official study title

Evaluation of Respiratory Muscle Strength and Pulmonary Functions in Volleyball Players Suffering From Covid-19

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Mar 9, 2021
Registry last updated
Apr 1, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.